Xin Rui Zhang1,2, Ngoc Chien Pham2, Nguyen Thi Thanh Ho2, VAN Anh Thi LE2, Jun-Kyu Park3, Sun-Young Nam4, Chan-Yeong Heo5,2. 1. Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul National University, Seoul, Republic of Korea. 2. Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. 3. CG Bio Co., Ltd., Seoul, Republic of Korea. 4. Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; 99261@snubh.org. 5. Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul National University, Seoul, Republic of Korea; lionheo@snu.ac.kr.
Abstract
BACKGROUND/AIM: The skin plays an important role in protecting the body from mechanical damage, microbial infection, ultraviolet radiation, and extreme temperatures. Many products as well as ongoing studies have focused on skin injury and repair; however, unlimited challenges are still being faced. Furthermore, the drugs that are currently on the market are not adequate to meet the increasing medical needs. This study aimed to discover whether our new product can efficiently promote wound repair and skin restoration. MATERIALS AND METHODS: ĩn this study, we applied a new AIMP1-derived peptide (AdP), NeoPep S, administered in two dose types (1 ppm and 3 ppm), and determined their effect on skin wound repair in rat models. Cell proliferation and inflammatory responses were assessed using immunofluorescence (IF) staining and ELISA assay. RESULTS: As expected, our results showed more rapid and satisfactory progress in wound closure upon treatment with NeoPep S 3 ppm than with NeoPep S 1 ppm. The 3 ppm peptide derived from AIMP1 protein, harmoniously interacted with the wound to promote re-epithelialization and collagen regeneration, as well as the down-regulation of several types of cytokines and chemokines, such as TNF-α, IL-6, IL-8, IL-lβ, MCP-1, and F4/80. Moreover, it was demonstrated to promote fibroblast proliferation, migration, and differentiation by TGF-βl and TGF-β3 modulation, as well as nitrite and reactive oxygen species scavenging. CONCLUSION: The novel peptide NeoPep S 3 ppm showed high effectiveness and safety in wound healing.
BACKGROUND/AIM: The skin plays an important role in protecting the body from mechanical damage, microbial infection, ultraviolet radiation, and extreme temperatures. Many products as well as ongoing studies have focused on skin injury and repair; however, unlimited challenges are still being faced. Furthermore, the drugs that are currently on the market are not adequate to meet the increasing medical needs. This study aimed to discover whether our new product can efficiently promote wound repair and skin restoration. MATERIALS AND METHODS: ĩn this study, we applied a new AIMP1-derived peptide (AdP), NeoPep S, administered in two dose types (1 ppm and 3 ppm), and determined their effect on skin wound repair in rat models. Cell proliferation and inflammatory responses were assessed using immunofluorescence (IF) staining and ELISA assay. RESULTS: As expected, our results showed more rapid and satisfactory progress in wound closure upon treatment with NeoPep S 3 ppm than with NeoPep S 1 ppm. The 3 ppm peptide derived from AIMP1 protein, harmoniously interacted with the wound to promote re-epithelialization and collagen regeneration, as well as the down-regulation of several types of cytokines and chemokines, such as TNF-α, IL-6, IL-8, IL-lβ, MCP-1, and F4/80. Moreover, it was demonstrated to promote fibroblast proliferation, migration, and differentiation by TGF-βl and TGF-β3 modulation, as well as nitrite and reactive oxygen species scavenging. CONCLUSION: The novel peptide NeoPep S 3 ppm showed high effectiveness and safety in wound healing.
Authors: Trung T Nguyen; Derong Ding; William R Wolter; Rocio L Pérez; Matthew M Champion; Kiran V Mahasenan; Dusan Hesek; Mijoon Lee; Valerie A Schroeder; Jeffrey I Jones; Elena Lastochkin; Margaret K Rose; Charles E Peterson; Mark A Suckow; Shahriar Mobashery; Mayland Chang Journal: J Med Chem Date: 2018-09-27 Impact factor: 7.446
Authors: Hye-Jin Hong; Hui Xuan Lim; Ju Han Song; Arim Lee; Eugene Kim; Daeho Cho; Edward P Cohen; Tae Sung Kim Journal: Cancer Immunol Immunother Date: 2015-11-27 Impact factor: 6.968
Authors: Jung Min Han; Nam Hoon Kwon; Jin Young Lee; Seung Jae Jeong; Hee Jung Jung; Hyeong Rae Kim; Zihai Li; Sunghoon Kim Journal: PLoS One Date: 2010-03-23 Impact factor: 3.240